Glanbia plc (ISE:GL9)
Ireland · Delayed Price · Currency is EUR | Market Cap | 3.72B |
| Revenue (ttm) | 3.35B |
| Net Income (ttm) | 102.54M |
| Shares Out | 242.42M |
| EPS (ttm) | 0.39 |
| PE Ratio | 38.87 |
| Forward PE | 12.75 |
| Dividend | 0.39 (2.55%) |
| Ex-Dividend Date | Aug 21, 2025 |
| Volume | 297,767 |
| Average Volume | 408,246 |
| Open | 15.27 |
| Previous Close | 15.29 |
| Day's Range | 15.20 - 15.34 |
| 52-Week Range | 9.20 - 15.44 |
| Beta | 0.44 |
| RSI | 67.92 |
| Earnings Date | Nov 5, 2025 |
About Glanbia
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; pro... [Read more]
Financial Performance
In 2024, Glanbia's revenue was $3.84 billion, a decrease of -29.23% compared to the previous year's $5.43 billion. Earnings were $164.70 million, a decrease of -52.18%.
Financial numbers in USD Financial StatementsNews
Glanbia plc (GLAPY) Q3 2025 Earnings Call Transcript
Glanbia plc (OTCPK:GLAPY) Q3 2025 Earnings Call November 5, 2025 3:30 AM EST Company Participants Liam Hennigan - Group Secretary & Head of Investor Relations Hugh McGuire - CEO & Executive Director M...
Glanbia plc 2025 Q3 - Results - Earnings Call Presentation
2025-11-05. The following slide deck was published by Glanbia plc in conjunction with their 2025 Q3 earnings call.
Longleaf Partners Global Fund Q3 2025 Notable Contributors & Detractors
Our investments are grounded in real assets and brands producing growing free cash flow per share. We believe the Fund's FCF today can go to a mid-teens FCF multiple on growing FCF per share. We belie...
Typhoo tea owner buys SlimFast UK and Europe in £20m deal
Supreme acquires business, which faces pressure from growth of weight loss drugs, from Irish firm Glanbia The owner of Typhoo tea has snapped up SlimFast’s UK and European business in a £20.1m deal as...
SlimFast UK and Europe snapped up by Supreme for £20.1m
Glanbia has sold off the meal replacement powders business amid pressure on the brand from the rapid growth of weight loss drugs.
Tirln shareholding in Glanbia to fall to 17.8pc as co-op moves to cancel 250m bond
Tirlns stake in Glanbia plc will drop to 17.8pc as the farmer-owned co-op confirmed it will sell 17m shares in the plc to fund the cancellation of a 250m exchangeable bond.
Glanbia to sell Slimfast US to Heartland Food Products group of US
Irish-based nutrition supplement maker Glanbia on Wednesday said it had agreed to sell its weight management brand SlimFast US to Heartland Food Products Group for an undisclosed sum.
Glanbia weighs impact of reciprocal tariffs on investment decisions
The tariffs imposed by President Donald Trump, and reciprocal taxes imposed by other countries on imports from the US, are prompting Glanbia to carefully assess its future capital allocation, accordin...
Glanbia plc 2025 Q2 - Results - Earnings Call Presentation
Glanbia plc (GLAPF) Q2 2025 Earnings Call Transcript
Glanbia plc reports 1H results
Glanbia: Slimming Market Shifts Are Taking A Toll
Glanbia Performance Nutrition and Opinions scoop top prize at MII All Ireland Marketing Awards
Glanbia Performance Nutrition in partnership with research company Opinions scooped the Grand Prix at the Marketing Institute Ireland (MII) All-Ireland Marketing Awards last night.
Tirln pushes ahead with Glanbia share spin-out to members
Tirlns board has announced a spin-out of shares in stock market-listed Glanbia from the co-op to individual members.
Flax Protein Markets and Companies Analysis Report 2025 with Forecasts to 2029 & 2034 - Featuring Glanbia Nutritionals, Grain Millers, Myprotein, Linwoods Health Foods, Bioriginal Food & Science Corp. and More
Explore the booming Flax Protein Market: projected to soar from $38.54B in 2024 to $56.42B by 2029, driven by the rise in plant-based diets and demand for minimally processed foods. Explore the boomin...
Wellness gains, shareholder pains: Glanbias structure under fire
Glanbia may be well positioned to ride the global wellness wave, but a growing number of its shareholders are questioning whether the companys current structure is the right vehicle to capitalise on i...
Should we care more about the ‘adjusted’ in THG’s adjusted Ebitda?
Myprotein, Glanbia, and a parting of the wheys
Glanbia shares surge as activist investor piles pressure on food group to split
A better-than-expected performance by food group Glanbia pushed its shares 10pc higher for a time on Wednesday, as an activist investor told its AGM that concerns about poor returns for shareholders a...
Glanbia shares jump after 'better than feared' first quarter
Shares in nutrition supplement maker Glanbia jumped 10% on Wednesday after analysts pointed to a "better than feared" first quarter performance that allowed the Irish group to maintain its full year e...
Richard Curran: Glanbias activist shareholder gives much food for thought in Kilkenny
Activist shareholder in Glanbia, Clearwater Capital, may not succeed in breaking up the Kilkenny- based plc but it knows how and when to push the buttons to maximum effect.
Activist investor seeks Tirlns backing for its radical plan to split up Glanbia
Glanbia shareholder Clearway Capital has gone direct to Tirln Co-op seeking support from the board and its members for a break-up of the PLC in a bid to lift its battered shares.
Glanbia plc (GLAPF) 2024 Full Year Results Earnings Call Transcript
Glanbia plc 2024 Q4 - Results - Earnings Call Presentation
Glanbia plc reports FY results
Supplements producer Glanbia's shares dive on profit warning
Shares in nutrition supplement maker Glanbia slid by 15% on Wednesday after it warned that it expects earnings to fall by up to 11% this year, hit by a longer than expected rise in the cost of whey, a...